Please use this identifier to cite or link to this item:
Title: Structural elucidation and immunoprophylactic studies of recombinant parasitic proteins for therapeutic intervention in human lymphatic filariasis
Researcher: Prince R Prabhu
Guide(s): Kaliraj P
Keywords: Immunoprophylactic, recombinant parasitic proteins, human lymphatic filariasis, x-ray crystallographic,Glutathione-S-transferase
Upload Date: 3-Feb-2014
University: Anna University
Completed Date: 2011
Abstract: Human lymphatic filariasis is an incapacitating vector borne disease and is the world s second leading cause of long-term disability. To worsen the condition there are no vaccines yet and vector control programs have limitations of insect resistance. The first part of the thesis deals with strategies to enhance the immunoprophylactic efficacy of filarial vaccine targets. The protection results correlates with humoral and cellular responses indicating the role of eukaryotic expression systems like P.pastoris in enhancing the immunogenicity of vaccine antigens. The second part of the thesis deals with X-ray crystallographic elucidation of Glutathione-S-transferase (GST) 3-D structure and conformational epitope analysis of Thioredoxin (TRX) 3-D structure for therapeutic intervention. The Wb-GST structure also revealed the presence of non-catalytic ligand binding sites (ligandin function) in the inter-subunit cleft, which can serve as a binding site for hydrophobic ligands. These crucial insights from structural data could be exploited for developing parasite-specific inhibitors. The recombinant Wb-TRX was sub-cloned, expressed and purification strategies were optimised for structural studies. Although TRX is a potential therapeutic target, it shares sequence homology with host enzyme which may lead to cross-reactivity. The current study for the first time reports that pichia expressed antigens combined with multiple-antigen mode is a promising vaccine strategy by virtue of ~80% reduction in worm burden. In regard with drug development approach, This is the first report on X-ray crystallographic determination of Wb-GST structure suggesting its potential as a drug target. Further, the study validates that the earlier reported protective epitopes (PC1) are a part of a dominant conformational epitope of Wb-TRX and also confirms its role in protective response by biochemical and structural analysis. newline newline newline
Pagination: xxvii, 256
Appears in Departments:Faculty of Technology

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File49.57 kBAdobe PDFView/Open
02_certificates.pdf1.06 MBAdobe PDFView/Open
03_abstract.pdf34.12 kBAdobe PDFView/Open
04_acknowledgement.pdf16.12 kBAdobe PDFView/Open
05_contents.pdf94.14 kBAdobe PDFView/Open
06_chapter 1.pdf75.4 kBAdobe PDFView/Open
07_chapter 2.pdf1.59 MBAdobe PDFView/Open
08_chapter 3.pdf1.3 MBAdobe PDFView/Open
09_chapter 4.pdf4.71 MBAdobe PDFView/Open
10_chapter 5.pdf41.28 kBAdobe PDFView/Open
11_appendices 1 to 3.pdf77.46 kBAdobe PDFView/Open
12_references.pdf130.33 kBAdobe PDFView/Open
13_publications.pdf25.96 kBAdobe PDFView/Open
14_vitae.pdf11.96 kBAdobe PDFView/Open

Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: